| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,300,000 | 1,346,700 | 1,412,800 | 1,513,800 | 1,805,300 |
|
Cost of Revenue
|
-1,344,300 | -1,235,500 | -1,137,400 | -1,141,600 | -1,189,900 |
|
Gross Profit
|
-44,300 | 111,200 | 275,400 | 372,200 | 615,400 |
| Selling, General and Administrative Expenses
|
-72,700 | -67,700 | -67,700 | -70,500 | -68,100 |
|
Research and Development Expenses
|
-84,400 | -78,300 | -83,100 | -87,600 | -89,500 |
| Provision Expense/Write-Back
|
900 | 900 | 2,900 | 3,000 | 1,700 |
| Other Income/Expense, Operating
|
26,600 | 11,300 | -400 | 1,900 | 53,800 |
|
Operating Income/Expenses
|
-129,600 | -133,800 | -148,300 | -153,200 | -102,100 |
|
Total Operating Profit/Loss
|
-173,900 | -22,600 | 127,100 | 219,000 | 513,300 |
| Total Net Finance Income/Expense
|
-42,700 | -38,200 | -24,900 | -500 | -8,500 |
| Net Investment Income
|
200 | 200 | -300 | 16,400 | -21,000 |
| Irregular Income/Expenses
|
-4,000 | -4,000 | -1,600 | -4,100 | 3,300 |
|
Non-Operating Income/Expenses, Total
|
-38,100 | -42,000 | -26,800 | 11,800 | -26,200 |
|
Pretax Income
|
-212,000 | -64,600 | 100,300 | 230,800 | 487,100 |
|
Provision for Income Tax
|
-14,700 | -13,300 | -33,100 | -29,500 | -52,700 |
|
Net Income from Continuing Operations
|
-226,700 | -77,900 | 67,200 | 201,300 | 434,400 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-226,700 | -77,900 | 67,200 | 201,300 | 434,400 |
|
Non-Controlling/Minority Interests
|
33,900 | 8,700 | -4,200 | -16,900 | -43,800 |
|
Net Income after Non-Controlling/Minority Interests
|
-192,800 | -69,200 | 63,000 | 184,400 | 390,600 |
|
Net Income Available to Common Stockholders
|
-192,800 | -69,200 | 63,000 | 184,400 | 390,600 |
|
Diluted Net Income Available to Common Stockholders
|
-192,800 | -69,200 | 63,000 | 184,400 | 390,600 |
|
Common Dividend per Share
|
0.20 | 0.20 | 1.20 | 1.20 | 3.00 |
| Basic EPS
|
-6.41 | -2.31 | 2.10 | 6.15 | 13.02 |
| Diluted EPS
|
-6.41 | -2.31 | 2.10 | 6.15 | 13.02 |
|
Basic Weighted Average Shares Outstanding
|
30,082.42 | 30,000 | 30,000 | 30,000 | 30,000 |
|
Diluted Weighted Average Shares Outstanding
|
30,082.42 | 30,000 | 30,000 | 30,000 | 30,000 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-165,800 | -24,900 | 124,000 | 233,800 | 489,300 |
|
EBITDA
|
290,200 | 318,400 | 362,500 | 436,300 | 671,000 |
|
Normalized EBITDA
|
294,300 | 322,400 | 364,100 | 440,400 | 671,600 |
12/31/2022 - 6/15/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade